By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Omeros Corporation 

1420 Fifth Avenue
Suite 2675
Seattle  Washington  98101  U.S.A.
Phone: 206-623-4688 Fax: 206-264-7856



Company News
Omeros Corporation (OMER) To Announce Second Quarter 2015 Financial Results On August 10, 2015 8/3/2015 7:35:18 AM
Omeros Corporation (OMER) Release: Omidria Approved For Commercialization Throughout The European Union And Additional Countries 8/3/2015 6:44:41 AM
FDA Grants "Fast Track" To Omeros Corporation (OMER)' Complement Inhibitor OMS721 For aHUS 7/23/2015 9:00:19 AM
Rajiv Shah, M.D., Appointed To Omeros Corporation (OMER)' Board Of Directors 6/17/2015 8:43:37 AM
Omeros Corporation (OMER)Announces Exclusive License Agreement For Omeros' Arthroscopic Product OMS103 6/16/2015 6:11:07 AM
Omeros Corporation (OMER) Release: Omidria Receives Positive Opinion From European Medicines Agency's Committee For Medicinal Products For Human Use 5/22/2015 6:10:38 AM
Omeros Corporation (OMER) Reports First Quarter 2015 Financial Results 5/11/2015 5:02:25 PM
Omeros Corporation (OMER) To Announce First Quarter 2015 Financial Results On May 11, 2015 5/5/2015 6:50:52 AM
Omeros Corporation (OMER) To Present At The 14th Annual Needham Healthcare Conference 4/10/2015 11:08:11 AM
Omeros Corporation (OMER) Announces The U.S. Commercial Launch Of Omidria 4/2/2015 6:39:03 AM